Naziheh Assarzadegan1, Elizabeth Thompson1, Kevan Salimian1, Matthias M Gaida2, Lodewijk A A Brosens3, Laura Wood1,4, Syed Z Ali1,4, Ralph H Hruban5,6. 1. Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21212, USA. 2. Institute of Pathology, University Medical Center Mainz, Mainz, Germany. 3. Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. 4. Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21212, USA. 5. Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21212, USA. rhruban@jhmi.edu. 6. Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21212, USA. rhruban@jhmi.edu.
Abstract
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient. PURPOSE: Informed clinical decisions in the treatment of IPMNs are first and foremost based on a deep understanding of the pathology of these lesions. CONCLUSIONS: Here we review the pathology of IPMNs, with an emphasis on the clinical relevance of the important features that characterize these lesions.
BACKGROUND: Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient. PURPOSE: Informed clinical decisions in the treatment of IPMNs are first and foremost based on a deep understanding of the pathology of these lesions. CONCLUSIONS: Here we review the pathology of IPMNs, with an emphasis on the clinical relevance of the important features that characterize these lesions.
Authors: Stefan Fritz; Moritz Schirren; Miriam Klauss; Frank Bergmann; Thilo Hackert; Werner Hartwig; Oliver Strobel; Lars Grenacher; Markus W Büchler; Jens Werner Journal: Surgery Date: 2012-07-06 Impact factor: 3.982
Authors: Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa Journal: Am J Surg Pathol Date: 2015-12 Impact factor: 6.394
Authors: Erick Riquelme; Yu Zhang; Liangliang Zhang; Maria Montiel; Michelle Zoltan; Wenli Dong; Pompeyo Quesada; Ismet Sahin; Vidhi Chandra; Anthony San Lucas; Paul Scheet; Hanwen Xu; Samir M Hanash; Lei Feng; Jared K Burks; Kim-Anh Do; Christine B Peterson; Deborah Nejman; Ching-Wei D Tzeng; Michael P Kim; Cynthia L Sears; Nadim Ajami; Joseph Petrosino; Laura D Wood; Anirban Maitra; Ravid Straussman; Matthew Katz; James Robert White; Robert Jenq; Jennifer Wargo; Florencia McAllister Journal: Cell Date: 2019-08-08 Impact factor: 41.582
Authors: Fikret Sahin; Anirban Maitra; Pedram Argani; Norihiro Sato; Naoki Maehara; Elizabeth Montgomery; Michael Goggins; Ralph H Hruban; Gloria H Su Journal: Mod Pathol Date: 2003-07 Impact factor: 7.842
Authors: N Volkan Adsay; Kambiz Merati; Olca Basturk; Christine Iacobuzio-Donahue; Edi Levi; Jeanette D Cheng; Fazlul H Sarkar; Ralph H Hruban; David S Klimstra Journal: Am J Surg Pathol Date: 2004-07 Impact factor: 6.394
Authors: Paul J Michaels; Elena F Brachtel; Brenna C Bounds; William R Brugge; Martha Bishop Pitman Journal: Cancer Date: 2006-06-25 Impact factor: 6.860
Authors: Giovanni Marchegiani; Mari Mino-Kenudson; Klaus Sahora; Vicente Morales-Oyarvide; Sarah Thayer; Cristina Ferrone; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-Del Castillo Journal: Ann Surg Date: 2015-05 Impact factor: 12.969
Authors: Kohei Fujikura; Waki Hosoda; Matthäus Felsenstein; Qianqian Song; Johannes G Reiter; Lily Zheng; Violeta Beleva Guthrie; Natalia Rincon; Marco Dal Molin; Jonathan Dudley; Joshua D Cohen; Pei Wang; Catherine G Fischer; Alicia M Braxton; Michaël Noë; Martine Jongepier; Carlos Fernández-Del Castillo; Mari Mino-Kenudson; C Max Schmidt; Michele T Yip-Schneider; Rita T Lawlor; Roberto Salvia; Nicholas J Roberts; Elizabeth D Thompson; Rachel Karchin; Anne Marie Lennon; Yuchen Jiao; Laura D Wood Journal: Gut Date: 2020-10-07 Impact factor: 23.059
Authors: Niall Brindl; Henning Boekhoff; Andrea S Bauer; Matthias M Gaida; Hien T Dang; Jörg Kaiser; Jörg D Hoheisel; Klaus Felix Journal: Cancers (Basel) Date: 2022-07-22 Impact factor: 6.575